• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Participation in "The 113th Congress of Japan Society of Aesthetic Surgery," May 2025

    6/17/25 10:51:32 PM ET
    $SBC
    Medical/Nursing Services
    Health Care
    Get the next $SBC alert in real time by email

    IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical") today announced that a total of 22 representatives, including Yoshiyuki Aikawa, CEO of SBC Medical, and doctors from Shonan Beauty Clinic, a clinic operated under the management support of SBC Medical Group, a consolidated subsidiary, presented their research findings at "The 113th Congress of Japan Society of Aesthetic Surgery."

    image1.jpegYoshiyuki Aikawa, CEO of SBC Medical Group Holdings Incorporated

    The Japan Society of Aesthetic Surgery (JSAS), one of Japan's leading professional societies in the field of aesthetic medicine, brings together doctors dedicated to shaping the future of the industry. "The 113th Congress of Japan Society of Aesthetic Surgery" was held over three days from Wednesday, May 28 to Friday, May 30, 2025, at The Okura Tokyo. Under the theme "TO BE THE BEST -The Journey of Knowledge Never Ends-," the congress was chaired in part by Dr. Ayaka Nishikawa, Director of Dermatology Department of Shonan Beauty Group, who served as Vice Chair of the event. The congress provided a valuable platform for in-depth discussions on international trends and future developments in aesthetic medicine, fostering both academic and clinical insights and promoting global collaboration among experts in the field.

    image2.pngDr. Ayaka Nishikawa, Director of Dermatology Department of Shonan Beauty Group, served as Vice Chair of this Congress

    At this congress, a total of 22 representatives from SBC Medical presented their research findings, including Yoshiyuki Aikawa, CEO of SBC Medical, Dr. Daisuke Nakamura, Chief Medical Director of Shonan Beauty Group, Dr. Kazuhiro Igawa, Representative Assistant of Shonan Beauty Group and Dr. Ayaka Nishikawa, who also served as Vice Chair of the congress. Each speaker shared insights cultivated through daily clinical practice and research in their respective fields of expertise. The event also featured lively discussions on global trends and future developments in aesthetic medicine, providing a valuable opportunity to deepen academic and clinical knowledge and to foster international collaboration.

    image4.jpegDr. Daisuke Nakamura, Chief Medical Director of Shonan Beauty Group     

    image3.jpegDr. Kazuhiro Igawa, Representative Assistant of Shonan Beauty Group

    In the rapidly evolving field of aesthetic medicine, the importance of both acquiring and sharing specialized knowledge continues to grow. As technological advancements drive increasingly diverse customer needs, it is essential not only to adopt cutting-edge technologies, but also to maintain a broad and multifaceted perspective. SBC Medical remains committed to contributing to the advancement of the aesthetic medicine industry by actively engaging with academic societies and research institutions, sharing our innovative initiatives, and incorporating the latest global knowledge and technologies into our practice.

    The 113th Congress of Japan Society of Aesthetic Surgery

    Venue:The Okura Tokyo

    Dates:Wednesday, May 28 – Friday, May 30, 2025

    Official website:https://square.umin.ac.jp/jsas113/index.html

    Presentation Topics

    Chair / Speaker Job TitleTitle
    Yoshiyuki AikawaCEO, SBC Medical Group Holdings【Special Program/Speaker】 Practical Strategies for Cosmetic Medical Business Management and Marketing

    【Special Lecture/Chair】The future of cosmetic medicine and AI
    Daisuke NakamuraChief Medical Director of Shonan Beauty Group,

    Chief of Breast Augmentation at SBC
    【Symposium/Speaker】Creating an attractive bust line - Fat injection breast augmentation and breast implant augmentation
    Kazuhiro IgawaRepresentative Assistant and Technical Advisor,

    Shonan Beauty Group
    【Symposium/Speaker】Rhinoplasty with an awareness of harmony by considering facial parts as fonts
    Ayaka NishikawaDirector of Dermatology

    Department of Shonan Beauty Group
    【Luncheon Seminar/Chair/Speaker】The Potential of Microneedle RF:Indications and Practical Combination Treatments in Skin Management

    【Invited Lecture/Chair】Unique Treatments and Techniques with injectable Agents A 35 Year Evolution

    【Symposium/Speaker】Challenges in Skin Tightening Devices: Insights from Single-Device Treatments with 6.78MHz Monopolar RF

    【Sponsored Seminar/Chair】"The WHY"? -Why do we do what we do as an aesthetics injector?

    【Presidential Special Program/Speaker】Evaluating the Impact of Different Approaches in Aesthetic Dermatology: A Post-Treatment Study in Identical Twins

    【Sponsored Seminar/Speaker】Fine fiber sheet for application after pico-second laser treatment
    Jiro KataokaArea Medical Director and Anti-Aging Expert Doctor【Panel Discussion/Speaker】Deep Plane Facelift for Japanese (Asians) ~My Experience and Ideas~

    【Video Lecture/Chair】Fundamentals and applications of Facelift Surgery: Strategies for Addressing Age-Related Changes
    Shoko TakahashiTop expert doctor in rejuvenation【Panel Discussion/Speaker】Patient education and combination treatment to maximize patient satisfaction with thread lifting
    Hiroaki TakizawaArea Doctor and Director of Jiyugaoka Clinic【Symposium/Speaker】Revision after double eyelid surgery with sub-brow blepharoplasty
    Eiko TanakaDirector of Takatsuki Hospital【Symposium/Chair/Speaker】Innovative Approaches to Improve Labia Majora Laxity: Minimizing Scars in Reduction Surgery
    Atsushi HayashiChief Technical Director【Panel Discussion/Speaker】Incidence of Post-inflammatory Hyperpigmentation with Picosecond Laser in Patients with Melasma
    Kanako MisonoSlimming Expert Doctor【Luncheon Seminar/Speaker】Cutting edge of Cryolipolysis: Maximize patient satisfaction with Coolsculpting
    Soichiro MorikawaAnti-aging treatment expert doctor【Luncheon Seminar/Speaker】Polynucleotide products and Hyaluronic Acid Filler
       

    Poster Presentations

     SpeakerJob TitleTitle
    Hiroshi OhjiーUsefulness of preoperative ultrasound examination in submandibular liposuction.
    Ayano OkudaExpert doctor in gynecological plastic surgeryDiversifying Intimate Area Treatments ~Changes and Current Status of Pubic Hair Removal and Female Genital plastic surgery at Our Clinic~
    Go KanazawaDirector of Hiroshima Clinic and Area Doctor for Hiroshima AreaLessons learned from the experience of removing limps formed by fat injection into the lower eyelid
    Kaito KuzushimaGinza Clinic Director

    Top Expert Doctor in Liposuction
    Asian Buttocks Contouring:witout fat injection 【Evaluated with 3D Vectra】
    Aiko SsasakiKawagoe Area Area

    Doctor and Director of Kawagoe Clinic
    Comparison of eyelid functions before and after completely transconjunctival embedding double eyelid blepharoplasty
    Yuka TakedaDirector of the Esaka InstituteThe usefulness of next generation needle Nanosoft Microneedles

    Lifting Effects and Technical Innovations in Full-Face Autologous Fat Grafting
    Ryuji TanakaHokkaido/Tohoku Area General ManagerApproach to the Management of Lower Eyelid Hollowness with Skin Laxity
    Mei NakayamaーBilateral symmetrical enlargement within a few months after upper arm liposuction : case report
    Ayaka NishikawaDirector of Dermatology

    Department of Shonan Beauty Group
    Fine fiber sheet for application after pico-second laser treatment
    Yu HirataDirector of Okayama Clinic and Area Doctor for Okayama AreaStudy on the direction of fat repositioning in transconjunctival blepharoplasty.
    Takashi YamamotoDirector of Nagoya InstituteExamination of the effects, satisfaction, and risks of orbital fat removal combined with the buried double method
    Akihiro YoshidaーTips to improve the success rate of transconjunctival double eyelid blepharoplasty suture removal
       

    About SBC Medical

    SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit https://sbc-holdings.com/

    Contacts

    In Asia:

    SBC Medical Group Holdings Incorporated

    Hikaru Fukui / Head of Investor Relations

    E-mail: [email protected]

    In the US:

    ICR LLC

    Bill Zima / Managing Partner

    Email: [email protected]

    Photos accompanying this announcement are available at: 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/136e0459-8d3b-47dd-a2bf-4822ee1cd39b

    https://www.globenewswire.com/NewsRoom/AttachmentNg/89b1bc1d-cf5f-4186-91af-feb0a2f4521b

    https://www.globenewswire.com/NewsRoom/AttachmentNg/4f56644f-8e83-40a3-9e00-aebf919f48ed

    https://www.globenewswire.com/NewsRoom/AttachmentNg/128a1a29-7e8d-4e34-b3bc-2e06fab1a6d3



    Get the next $SBC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBC

    DatePrice TargetRatingAnalyst
    3/6/2026$8.00Buy
    BTIG Research
    More analyst ratings

    $SBC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SBC Medical Group Holdings Incorporated

    4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    3/10/26 9:54:07 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Yamazaki Miki

    3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/18/25 4:56:42 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: New insider Aikawa Yoshiyuki claimed ownership of 94,192,433 shares (SEC Form 3)

    3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/9/25 7:00:13 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    SEC Filings

    View All

    SEC Form 10-K filed by SBC Medical Group Holdings Incorporated

    10-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 7:31:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 6:50:43 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    1/5/26 7:00:29 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (NASDAQ:SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy. The Q&A highlights several key themes, including: Improving unit economics, with Q4 average revenue per visit increasing 11% year over year to $316, signa

    3/31/26 10:12:55 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Next-Generation Wellness Strategy "SBC Wellness 2.0"

    Pioneering the "Performance Medicine" category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced "SBC Wellness 2.0," a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/SBC Medical Announces Next-Generation Wellness

    3/24/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Leadership Updates

    Live Leadership Updates

    View All

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center

    7/14/25 9:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

    IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

    7/1/25 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Financials

    Live finance-specific insights

    View All

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results

    IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.  Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company's financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remark

    3/13/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 mill

    11/14/25 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    10/1/24 9:00:18 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/24/24 9:07:03 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/23/24 9:02:53 AM ET
    $SBC
    Medical/Nursing Services
    Health Care